Sharma SK - Search Results

1

A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian Cancer.

Fung K, Sharma SK, Keinänen O, Roche KL, Lewis JS, Zeglis BM. Fung K, et al. Among authors: sharma sk. Mol Pharm. 2020 Aug 3;17(8):3140-3147. doi: 10.1021/acs.molpharmaceut.0c00437. Epub 2020 Jul 16. Mol Pharm. 2020. PMID: 32644804 Free PMC article.

2

Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.

Sharma SK, Sevak KK, Monette S, Carlin SD, Knight JC, Wuest FR, Sala E, Zeglis BM, Lewis JS. Sharma SK, et al. J Nucl Med. 2016 May;57(5):771-6. doi: 10.2967/jnumed.115.167072. Epub 2016 Feb 2. J Nucl Med. 2016. PMID: 26837339 Free PMC article.

3

Molecular Imaging of Ovarian Cancer.

Sharma SK, Nemieboka B, Sala E, Lewis JS, Zeglis BM. Sharma SK, et al. J Nucl Med. 2016 Jun;57(6):827-33. doi: 10.2967/jnumed.115.172023. Epub 2016 Apr 28. J Nucl Med. 2016. PMID: 27127223 Free PMC article. Review.

4

Site-Specifically Labeled Antibody-Drug Conjugate for Simultaneous Therapy and ImmunoPET.

Adumeau P, Vivier D, Sharma SK, Wang J, Zhang T, Chen A, Agnew BJ, Zeglis BM. Adumeau P, et al. Among authors: sharma sk. Mol Pharm. 2018 Mar 5;15(3):892-898. doi: 10.1021/acs.molpharmaceut.7b00802. Epub 2018 Feb 2. Mol Pharm. 2018. PMID: 29356543 Free PMC article.

5

ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody.

Sharma SK, Mack KN, Piersigilli A, Pourat J, Edwards KJ, Keinänen O, Jiao MS, Zhao H, White B, Brooks CL, de Stanchina E, Madiyalakan MR, Hollingsworth MA, Radhakrishnan P, Lewis JS, Zeglis BM. Sharma SK, et al. Clin Cancer Res. 2022 Mar 1;28(5):948-959. doi: 10.1158/1078-0432.CCR-21-1798. Clin Cancer Res. 2022. PMID: 34907079 Free PMC article.

6

Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer.

Sharma SK, Pourat J, Abdel-Atti D, Carlin SD, Piersigilli A, Bankovich AJ, Gardner EE, Hamdy O, Isse K, Bheddah S, Sandoval J, Cunanan KM, Johansen EB, Allaj V, Sisodiya V, Liu D, Zeglis BM, Rudin CM, Dylla SJ, Poirier JT, Lewis JS. Sharma SK, et al. Cancer Res. 2017 Jul 15;77(14):3931-3941. doi: 10.1158/0008-5472.CAN-17-0299. Epub 2017 May 9. Cancer Res. 2017. PMID: 28487384 Free PMC article.

7

Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models.

Sharma SK, Chow A, Monette S, Vivier D, Pourat J, Edwards KJ, Dilling TR, Abdel-Atti D, Zeglis BM, Poirier JT, Lewis JS. Sharma SK, et al. Cancer Res. 2018 Apr 1;78(7):1820-1832. doi: 10.1158/0008-5472.CAN-17-1958. Epub 2018 Jan 23. Cancer Res. 2018. PMID: 29363548 Free PMC article.

8

Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging.

Vivier D, Sharma SK, Zeglis BM. Vivier D, et al. Among authors: sharma sk. J Labelled Comp Radiopharm. 2018 Jul;61(9):672-692. doi: 10.1002/jlcr.3628. Epub 2018 May 14. J Labelled Comp Radiopharm. 2018. PMID: 29665104 Free PMC article. Review.

9

The Impact of FcγRI Binding on Immuno-PET.

Vivier D, Sharma SK, Adumeau P, Rodriguez C, Fung K, Zeglis BM. Vivier D, et al. Among authors: sharma sk. J Nucl Med. 2019 Aug;60(8):1174-1182. doi: 10.2967/jnumed.118.223636. Epub 2019 Feb 7. J Nucl Med. 2019. PMID: 30733320 Free PMC article.

10

The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and In vivo Performance of ⁸⁹Zr-DFO-Pertuzumab.

Vivier D, Fung K, Rodriguez C, Adumeau P, Ulaner GA, Lewis JS, Sharma SK, Zeglis BM. Vivier D, et al. Among authors: sharma sk. Theranostics. 2020 Jan 1;10(4):1746-1757. doi: 10.7150/thno.39089. eCollection 2020. Theranostics. 2020. PMID: 32042334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,249 results

Search Page